Mostrar 1 - 3 resultats de 3 per cerca 'A. E. van Leeuwen', hora de la petició: 0.02sec Refinar resultats
  1. 1
    Personalized surveillance and aftercare for non-metastasized breast cancer: the NABOR study protocol of a multiple interrupted time series design

    Personalized surveillance and aftercare for non-metastasized breast cancer: the NABOR study protocol of a multiple interrupted time series design per A. Klaassen-Dekker, C. H. C. Drossaert, M. C. Van Maaren, A. E. Van Leeuwen-Stok, V. P. Retel, J. C. Korevaar, S. Siesling, on behalf of the NABOR project group

    Publicat 2023-11-01
    Obtenir text complet
    Article
  2. 2
    Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade

    Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade per M. C. Liefaard, A. van der Voort, M. van Seijen, B. Thijssen, J. Sanders, S. Vonk, L. Mittempergher, R. Bhaskaran, L. de Munck, A. E. van Leeuwen-Stok, R. Salgado, H. M. Horlings, E. H. Lips, G. S. Sonke

    Publicat 2024-04-01
    Obtenir text complet
    Article
  3. 3
    BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancer

    BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancer per M. C. Liefaard, A. van der Voort, M. S. van Ramshorst, J. Sanders, S. Vonk, H. M. Horlings, S. Siesling, L. de Munck, A. E. van Leeuwen, M. Kleijn, L. Mittempergher, M. M. Kuilman, A. M. Glas, J. Wesseling, E. H. Lips, G. S. Sonke

    Publicat 2023-06-01
    Obtenir text complet
    Article

Eines de cerca: